These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ. J Am Coll Cardiol; 2013 Nov 19; 62(21):2000-2007. PubMed ID: 23916930 [Abstract] [Full Text] [Related]
24. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital. Sinha AM, Bense J, Hohenforst-Schmidt W. J Interv Card Electrophysiol; 2021 Nov 19; 62(2):401-407. PubMed ID: 33200285 [Abstract] [Full Text] [Related]
26. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death. Elbayomi M, Weyand M, Seitz T, Harig F. Ann Noninvasive Electrocardiol; 2023 Mar 19; 28(2):e13048. PubMed ID: 36723848 [Abstract] [Full Text] [Related]
28. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A, Zareba W, Moss AJ. Pacing Clin Electrophysiol; 2010 Mar 19; 33(3):353-67. PubMed ID: 19889186 [Abstract] [Full Text] [Related]
29. Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days. Dreher TC, El-Battrawy I, RÖger S, Rosenkaimer SL, Gerhards S, Kuschyk J, Borggrefe M, Akin I. In Vivo; 2020 Mar 19; 34(6):3601-3610. PubMed ID: 33144474 [Abstract] [Full Text] [Related]
30. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections. Castro L, Pecha S, Linder M, Vogler J, Gosau N, Meyer C, Willems S, Reichenspurner H, Hakmi S. J Cardiothorac Surg; 2017 Nov 25; 12(1):99. PubMed ID: 29178898 [Abstract] [Full Text] [Related]
35. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort. Zylla MM, Hillmann HAK, Proctor T, Kieser M, Scholz E, Zitron E, Katus HA, Thomas D. Heart Vessels; 2018 Nov 25; 33(11):1390-1402. PubMed ID: 29721674 [Abstract] [Full Text] [Related]
36. Wearable Cardioverter-Defibrillators following Cardiac Surgery-A Single-Center Experience. Heimeshoff J, Merz C, Ricklefs M, Kirchhoff F, Haverich A, Bara C, Kühn C. Thorac Cardiovasc Surg; 2019 Mar 25; 67(2):92-97. PubMed ID: 29925094 [Abstract] [Full Text] [Related]
37. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry. Veltmann C, Winter S, Duncker D, Jungbauer CG, Wäßnig NK, Geller JC, Erath JW, Goeing O, Perings C, Ulbrich M, Roser M, Husser D, Gansera LS, Soezener K, Malur FM, Block M, Fetsch T, Kutyifa V, Klein HU. Clin Res Cardiol; 2021 Jan 25; 110(1):102-113. PubMed ID: 32377784 [Abstract] [Full Text] [Related]
38. Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses. Olgin JE, Lee BK, Vittinghoff E, Morin DP, Zweibel S, Rashba E, Chung EH, Borggrefe M, Hulley S, Lin F, Hue TF, Pletcher MJ. J Cardiovasc Electrophysiol; 2020 May 25; 31(5):1009-1018. PubMed ID: 32083365 [Abstract] [Full Text] [Related]